Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,018 public trials 2,560 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

NCT06517719

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Novartis Investigative Site Konstanz, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Stuttgart, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Regensburg, Bavaria, Germany
View all 38 locations
View Trial Details
Recruiting

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

NCT07270666

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

NCT05990192

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • St James's University Hospital Leeds, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • Western General Hospital Edinburgh, Scotland, United Kingdom
View Trial Details
Recruiting

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

NCT05887609

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope Lennar Irvine, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions